Substance P causes seizures in neurocysticercosis

PLoS Pathogens

Volumn 8, Issue 2, 2012, Pages

  Robinson, Prema ^a   Garza, Armandina ^a   Weinstock, Joel ^b   Serpa, Jose A ^a   Goodman, Jerry Clay ^a   Eckols, Kristian T ^a   Firozgary, Bahrom ^a   Tweardy, David J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BIOPSY; CONTROLLED STUDY; FEMALE; GRANULOMA; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROCYSTICERCOSIS; NONHUMAN; RAT; SEIZURE; WILD TYPE;

ANIMALS; BRAIN; BRAIN DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GRANULOMA; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUROCYSTICERCOSIS; NEUROKININ-1 RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SEIZURES; SUBSTANCE P; TAENIA;

MUS; RODENTIA; VERMES;

EID: 84860904836     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002489     Document Type: Article

References (39)

1. Singhi P, (2011) Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol 53: 600-609.
2. Shandera WX, Kass JS, (2006) Neurocysticercosis: current knowledge and advances. Curr Neurol Neurosci Rep 6: 453-459.
3. Cruz ME, Schantz PM, Cruz I, Espinosa P, Preux PM, et al. (1999) Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 28: 799-803.
4. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325-327.
5. White AC Jr, (2000) Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 51: 187-206.
6. Murthy JM, Yangala R, (1998) Etiological spectrum of symptomatic localization related epilepsies: a study from South India. J Neurol Sci 158: 65-70.
7. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, et al. (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608-613.
8. Cuetter AC, Garcia-Bobadilla J, Guerra LG, Martinez FM, Kaim B, (1997) Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis 24: 157-164.
9. Escobar A, (1983) Cysticercosis of the central nervous system. In: Palacios E, Rodriguez-Carbajal J, Taveras J, editors. Springfield, III: Charles C Thomas, Publisher.
10. Gutierrez Y, (1990) Diagnostic pathology of parasitic infection with clinical correlation Philadelphia Lea and Febiger pp. 432-459.
11. Riduara Sanz C, (1987) Host response in childhood neurocysticercosis. Child's Nerv Syst 3: 206-207.
12. Weinstock JV, Blum A, Walder J, Walder R, (1988) Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 141: 961-966.
13. Maggi CA, (1997) The effects of tachykinins on inflammatory and immune cells. Regul Pept 70: 75-90.
14. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD, (1997) Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159: 5654-5660.
15. Cook GA, Elliott D, Metwali A, Blum AM, Sandor M, et al. (1994) Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J Immunol 152: 1830-1835.
16. Goode T, O'Connell J, Sternini C, Anton P, Wong H, et al. (1998) Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J Immunol 161: 2232-2240.
17. Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, et al. (2000) Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98: 585-598.
18. Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG, (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci U S A 96: 5286-5291.
19. Liu H, Cao Y, Basbaum AI, Mazarati AM, Sankar R, et al. (1999) Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc Natl Acad Sci U S A 96: 12096-12101.
20. Robinson P, Atmar RL, Lewis DE, White AC Jr, (1997) Granuloma cytokines in murine cysticercosis. Infect Immun 65: 2925-2931.
21. Robinson P, White AC, Lewis DE, Thornby J, David E, et al. (2002) Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect Immun 70: 4534-4538.
22. Stringer ML, White AC Jr, Robinson P, (2003) Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 183: 532-536.
23. Patil S, Robinson P, Actor JK, Baig S, White AC Jr, (2006) Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J Parasitol 92: 738-741.
24. Kunz J, Kalinna B, Watschke V, Geyer E, (1989) Taenia crassiceps metacestode vesicular fluid antigens shared with the Taenia solium larval stage and reactive with serum antibodies from patients with neurocysticercosis. Zentralbl Bakteriol 271: 510-520.
25. Larralde C, Montoya RM, Sotelo J, Hayunga J, Sciutto E, et al. (1990) Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginata bovine cysticercosis, and human E. granulosus hydatidosis. Bull Soc Fr Parasitol 8: S8B.
26. Villa O, Kuhn R, (1991) Antigenic and immunogenic analysis of Taenia crassiceps and Taenia solium using sera from their natural intermediate hosts. ASB Bull 39: 99-105.
27. Sciutto E, Fragoso G, Baca M, De la Cruz V, Lemus L, et al. (1995) Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infect Immun 63: 2277-2281.
28. Vezzani A, Balosso S, Ravizza T, (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797-803.
29. Rao RS, Prakash A, Medhi B, (2009) Role of different cytokines and seizure susceptibility: a new dimension towards epilepsy research. Indian J Exp Biol 47: 625-634.
30. Nalivaiko E, Michaud JC, Soubrie P, Le Fur G, Feltz P, (1997) Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 78: 745-757.
31. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, et al. (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389-392.
32. Del Brutto OH, (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44: 1706-1709.
33. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, et al. (2008) Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099-1105.
34. Nash TE, Patronas NJ, (1999) Edema associated with calcified lesions in neurocysticercosis. Neurology 53: 777-781.
35. Nash TE, Pretell EJ, Garcia HH, (2001) Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis 33: 1649-1653.
36. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, et al. (1998) Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392: 390-394.
37. Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP, (1996) Neurogenic amplification of immune complex inflammation. Science 273: 1722-1725.
38. Garza A, Weinstock JV, Robinson P, (2008) Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection. J Parasitol 94: 1253-1258.
39. Racine RJ, (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.